Abstract：
BACKGROUND:Ovarian carcinoma is a common, and often deadly, gynecological cancer. Mutations in BRCA1 and BRCA2 genes are present in at least a fifth of patients. Uncovering other genes that become mutated subsequent to BRCA1/BRCA2 inactivation during cancer development will be helpful for more effective treatments. METHODS:We performed exome sequencing on the blood, primary tumor, omental metastasis and recurrence following therapy with carboplatin and paclitaxel, from a patient carrying a BRCA1 S1841R mutation. RESULTS:We observed loss of heterozygosity in the BRCA1 mutation in the primary and subsequent tumors, and somatic mutations in the TP53 and NF1 genes were identified, suggesting their role along with BRCA1 driving the tumor development. Notably, we show that exome sequencing is effective in detecting large chromosomal rearrangements such as deletions and amplifications in cancer. We found that a large deletion was present in the three tumors in the regions containing BRCA1, TP53, and NF1 mutations, and an amplification in the regions containing MYC. We did not observe the emergence of any new mutations among tumors from diagnosis to relapse after chemotherapy, suggesting that mutations already present in the primary tumor contributed to metastases and chemotherapy resistance. CONCLUSIONS:Our findings suggest that exome sequencing of matched samples from one patient is a powerful method of detecting somatic mutations and prioritizing their potential role in the development of the disease.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Zhang J,Shi Y,Lalonde E,Li L,Cavallone L,Ferenczy A,Gotlieb WH,Foulkes WD,Majewski Jdoi
10.1186/1471-2407-13-146subject
Has Abstractpub_date
2013-03-22 00:00:00pages
146issn
1471-2407pii
1471-2407-13-146journal_volume
13pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Lung cancer patients with an activating mutation in the EGFR (epidermal growth factor receptor) can develop resistance to erlotinib treatment, which is often mediated by the T790M resistance mutation in EGFR. The difficulties in obtaining biopsies at progression make it challenging to investigate the appeara...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4108-0
更新日期：2018-02-15 00:00:00
abstract：BACKGROUND:Inflammation has been implicated as an etiological factor in several human cancers, including prostate cancer. Allelic variants of the genes involved in inflammatory pathways are logical candidates as genetic determinants of prostate cancer risk. The purpose of this study was to investigate whether single nu...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-382
更新日期：2008-12-19 00:00:00
abstract：BACKGROUND:Mounting evidence demonstrates a causal role for S100 proteins in tumourigenesis and several S100 isoforms have shown utility as biomarkers of several types of cancer. The S100 family is comprised of 21 small isoforms, many of them implicated in important cellular functions such as proliferation, motility an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1217-x
更新日期：2015-03-29 00:00:00
abstract：BACKGROUND:Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancers, and is the leading cause of cancer deaths. Radiation therapy (RT), alone or in combination with chemotherapy, is the standard of care for curative intent treatment of patients with locally advanced or inoperable NSCLC. The ability to intens...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-14-740
更新日期：2014-10-02 00:00:00
abstract：BACKGROUND:MicroRNA-21 (miR-21) is up-regulated in many cancers, including colorectal cancer (CRC). Nevertheless, the function of miR-21 in CRC and the mechanism underlying that function is still unclear. METHODS:After analyzing the expression of miR-21 and Sec23A in CRC cell lines, we transfected the highest miR-21 e...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2628-z
更新日期：2016-08-05 00:00:00
abstract：BACKGROUND:Hepatocyte carcinoma (HCC) is one of the most common malignancies worldwide. Despite many achievements in diagnosis and treatment, HCC mortality remains high due to the malignant nature of the disease. Novel approaches, especially for targeted therapy, are being extensively explored. Gene therapy is ideal fo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1339-1
更新日期：2015-04-29 00:00:00
abstract：BACKGROUND:In vitro and in vivo studies have suggested that osteopontin (OPN) is associated with many types of cancers. However, no studies have reported the incidence of OPN polymorphisms and the risk of gastric cancer. The aim of this study was to investigate the association between OPN polymorphisms and gastric canc...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-477
更新日期：2012-10-16 00:00:00
abstract：BACKGROUND:Breast cancer is the most common female cancer worldwide. The lifetime risk of a woman being diagnosed with breast cancer is approximately 12.5%. For women who carry the deleterious mutation in either of the BRCA genes, BRCA1 or BRCA2, the risk of developing breast or ovarian cancer is significantly increase...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-138
更新日期：2013-03-21 00:00:00
abstract：BACKGROUND:Classical in vitro wound-healing assays and other techniques designed to study cell migration and invasion have been used for many years to elucidate the various mechanisms associated with metastasis. However, many of these methods are limited in their ability to achieve reproducible, quantitative results th...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-198
更新日期：2008-07-14 00:00:00
abstract：BACKGROUND:The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors are increasingly recognised to be a common pitfall of PET/CT studies. CASE PRESENTATION:We r...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-147
更新日期：2007-08-03 00:00:00
abstract：BACKGROUND:To investigate on expressions and clinical significances of CD133 protein and vasculogenic mimicry (VM) in primary non-small cell lung cancer (NSCLC). METHODS:The specimens of NSCLC from 305 Chinese patients with follow-up were analyzed for CD133 protein expression and VM by immunohistochemical and histoche...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-535
更新日期：2012-11-21 00:00:00
abstract：BACKGROUND:Breast cancer survivors have an elevated risk of cognitive impairment compared to age-matched women without cancer. Causes of this impairment are complex, including both treatment and psychological factors. Mindfulness-based interventions, which have been shown to improve cognitive function in the general po...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5065-3
更新日期：2018-11-26 00:00:00
abstract：BACKGROUND:MEK1 (MAP2K1) and MEK2 (MAP2K2) are closely related dual-specificity protein kinases which function by phosphorylating both serine/threonine and tyrosine residues of their substrates ERK1 and ERK2, controlling fundamental cellular processes that include cell growth and proliferation. To investigate the progn...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2869-x
更新日期：2016-10-28 00:00:00
abstract：BACKGROUND:Aberrant spliced isoforms are specifically associated with cancer progression and metastasis. The cytoplasmic adaptor CRKL (v-crk avian sarcoma virus CT10 oncogene homolog-like) is a CRK like proto-oncogene, which encodes a SH2 and SH3 (src homology) domain-containing adaptor protein. CRKL is tightly linked ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5671-8
更新日期：2019-05-27 00:00:00
abstract：BACKGROUND:Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-85
更新日期：2009-03-17 00:00:00
abstract：BACKGROUND:Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and their molecular transducers were analysed in terms of mutations, amplifications and over-expression in a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-631
更新日期：2010-11-18 00:00:00
abstract：BACKGROUND:Surgical resection remains the only curative treatment for pancreatic cancer and is associated with significant post-operative morbidity and mortality. Patients eligible for surgery, increasingly receive neo-adjuvant therapy before surgery or adjuvant therapy afterward, inherently exposing them to toxicity. ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07733-0
更新日期：2021-01-09 00:00:00
abstract：BACKGROUND:Aprepitant is an FDA-approved medication for chemotherapy-induced nausea and vomiting. It blocks substance P binding to neurokinin-1; substance P has been implicated in itch pathways both as a local and global mediator. CASE PRESENTATIONS:We report a series of four patients, diagnosed with cutaneous T-cell ...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-017-3194-8
更新日期：2017-03-16 00:00:00
abstract：BACKGROUND:The incidence of Cholangiocellular Carcinoma (CCA) is increasing in the western world. The tumour has a high proportion of desmoplastic stroma and is correlated with a worse prognosis when cancer associated myofibroblasts (CAFs) are present. Recent studies showed promising results after liver transplantation...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2360-8
更新日期：2016-05-20 00:00:00
abstract：BACKGROUND:Patients with unresectable malignant biliary obstruction have limited life expectancy because of limited stent patency and tumor progression. The aim of our study was to retrospectively evaluate the safety and efficacy of combining intraductal RFA with biliary metal stent placement for patients with malignan...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3278-5
更新日期：2017-04-24 00:00:00
abstract：BACKGROUND:Being the most common cancer among women worldwide, it is vital to be well-aware of breast cancer risk factors, symptoms and curability. However, few studies have reported breast cancer literacy in students using a validated instrument. METHODS:A cross-sectional study was conducted among students of grades ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2166-8
更新日期：2016-02-18 00:00:00
abstract：BACKGROUND:Systemic inflammation has been implicated in cancer development and progression. This study examined the best cutoff value of erythrocyte sedimentation rate (ESR) in diffuse large B-cell lymphoma (DLBCL) patients. METHODS:The relationship between ESR and clinical characteristics was analyzed in 182 DLBCL pa...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4914-4
更新日期：2018-10-19 00:00:00
abstract：BACKGROUND:The aim of the present study was to investigate the association between matrix metalloproteinase-9 (MMP-9) expression with BRAF V600E mutation and clinicopathological features, in Iranian papillary thyroid cancer (PTC) patients. METHODS:In total, 90 participants including 60 PTC patients (15 males and 45 fe...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5112-0
更新日期：2018-12-03 00:00:00
abstract：BACKGROUND:Twist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis. It is known to induce epithelial-mesenchymal transition (EMT). In this study, we evaluated the expression of twist and its effect on cell migration in hepatocellular carcinoma (HCC). METHODS:We exam...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-240
更新日期：2009-07-18 00:00:00
abstract：BACKGROUND:Loss of DNA mismatch repair (MMR) in humans, mainly due to mutations in the hMLH1 gene, is linked to hereditary nonpolyposis colorectal cancer (HNPCC). Because not all MLH1 alterations result in loss of MMR function, accurate characterization of variants and their classification in terms of their effect on M...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-382
更新日期：2009-10-28 00:00:00
abstract：BACKGROUND:Adequate circadian timing of cancer treatment schedules (chronotherapy) can enhance tolerance and efficacy several-fold in experimental and clinical situations. However, the optimal timing varies according to sex, genetic background and lifestyle. Here, we compute the individual phase of the Circadian Timing...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2319-9
更新日期：2016-04-21 00:00:00
abstract：BACKGROUND:Reports on childhood cancer survivors estimated cumulative probability of developing secondary neoplasms vary from 3.3% to 25% at 25 years from diagnosis, and the risk of developing another cancer to several times greater than in the general population. METHODS:In our retrospective study, we have used the c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-27
更新日期：2007-02-02 00:00:00
abstract：BACKGROUND:Sorafenib is an orally active multikinase tyrosine kinase inhibitor (TKI) that targets B-type Raf kinase (BRAF), vascular endothelial growth factor receptors (VEGFR) 1 and 2, and rearranged during transfection (RET), inducing anti-angiogenic and pro-apoptotic actions in a wide range of solid tumors. A side e...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2060-4
更新日期：2016-01-19 00:00:00
abstract：BACKGROUND:To date, no single colorectal cancer (CRC) screening strategy has been determined to be applicable worldwide. In China, a CRC screening protocol that combines double fecal immunochemical tests (FITs) and a high-risk factor questionnaire (HRFQ) as the first stage of screening and colonoscopy as the second sta...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5191-y
更新日期：2019-01-10 00:00:00
abstract：BACKGROUND:Compared with World Health Organization-defined acute myeloid leukaemia (AML) not otherwise specified, patients with AML with myelodysplasia-related changes (AML-MRC) are generally older and more likely to have poor-risk cytogenetics, leading to poor response and prognosis. More than one-half of all older (≥...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-017-3803-6
更新日期：2017-12-14 00:00:00
